§ 516.28. Publication of MUMS-drug designations.
97 words·~1 min read·
/us/cfr/t21/s§ 516.28·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
FDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Dockets Management Staff, and will contain the following information for each MUMS-designated drug:
(a)The name and address of the sponsor;
(b)The established name and trade name, if any, of the drug;
(c)The dosage form of the drug;
(d)The species and the proposed intended use for which MUMS-drug designation was granted; and
(e)The date designation was granted. [72 FR 41017, July 26, 2007, as amended at 88 FR 45066, July 14, 2023]